Group 2 was a sample of 20 patients with osteoradionecrosis of the jaws orn, the diagnosis being established following the criteria described by thorn et al. Orally administered bps may induce recurrent ulcers with. Osteonecrosis of jaws onj might be old, dating back a century in the form of phossy jaw. Osteonecrosis of the jaw onj, a condition characterized by necrotic. To evaluate the level of knowledge of dentists from plovdiv, bulgaria, about possible complications of bisphosphonate therapy of patients in dental practice. As a rheumatologist who has seen and managed bisphosphonate related osteonecrosis of the jaws fung e, medwatch case reports. The text below is from the executive summary of a european society on clinical and economic aspects of osteoporosis and foundation for research on osteoporosis and other bone diseases working group meeting december 2006. Review, clinical implications and case report, head and neck pathology, 10. Cases of osteonecrosis of the jaw in connection with the use of bisphosphonates were reported in 2003. The 1 to 2mm lucency between the root of the tooth and the lamina dura corresponds with the space for the periodontal ligament. Bisphosphonatesrelated osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy. Cdho factsheet bisphosphonaterelated osteonecrosis of the jaw. Concept, diagnosis and classification of bisphosphonate. Oral bisphosphonate induced osteonecrosis of the jaws is less common, less severe, and more likely to undergo spontaneous resolution or resolution with local debridements after a drug holiday and return of bone remodeling documented by the morning fasting ctx test than its counterpart caused by intravenous bisphosphonates.
Osteonecrosis of the jaw and bisphosphonates in cancer. Sclerostin antibody do not induce osteonecrosis of the jaw onj in rats with. Medical comorbidities included the malignancy itself 97. Periapical disease and bisphosphonates induce osteonecrosis. This complication usually presents after a minor local trauma during a dental treatment. However, these imaging resources are not able to show the difference between bronj and other causes of bone exposure in the jaw, such as osteoradionecrosis, osteomyelitisrelated osteonecrosis of the jaw, or steroid induced osteonecrosis.
Medicationrelated osteonecrosis of the jaw in patients. Nbisphosphonates cause gastric epithelial injury independent of effect on. Osteonecrosis of the jaw associated with bisphosphonate. Osteonecrosis of the jaws and bisphosphonates springerlink. Several recent reports have described osteonecrosis of the jaws onj associated with the use of bisphosphonates. Imaging findings of bisphosphonateassociated osteonecrosis.
Prevention of osteonecrosis of the jaw onj in patients on bisphosphonate therapies purpose the nsw centre for oral health strategy recognises that there has been growing concern regarding the number of patients who take bisphosphonate agents, thereby placing them at potential risk for developing osteonecrosis of the jaws, especially. Since intravenous administration leads to a higher drug exposure than the oral route, osteonecrosis related to oral bisphosphonate therapy is less common than that of related to intravenous forms such as zolendronate which is also more potent than oral bisphosphonates. Orn is the result of hypocellularity, hypovascularity, and tissue hypoxia following ionizing radiation. This complication usually presents after simple dentoalveolar surgery. The disease is characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region. Bisphosphonate osteonecrosis was first identified in 2001.
Bisphosphonate associated osteonecrosis of the jaw is an important condition seen most commonly in oncology patients receiving highdose intravenous bisphosphonates. This is a rare condition associated with dental extractions and bone therapies often used in cancer treatments, and occurs when jaw bones become. The histopathologic features described herein may explain the physiopathology of this disease, which is different from other necrotizing and inflammatory conditions such as osteoradionecrosis and suppurative osteomyelitis. Nih funding opportunities and notices in the nih guide for grants and contracts. Sep 17, 2015 osteonecrosis of the jaws definition onj sawatari and marx 2007 exposed bone in the mandible or maxilla that fails to heal within 8 weeks in a patient receiving, or who has received, a systemic bisphosphonate, and who has not received local radiation therapy to the jaws. Pdf recently, bisphosphonates bps have been widely used in medical practice as antiresorptive agents owing to their antiosteoclatic action. Pdf bisphosphonateinduced osteonecrosis of the jaw. Osteonecrosis of the jaw is very painful and can lead to serious complications, including ulcerations within the lining of the mouth, infection, and breakdown of the jawbone with disfigurement. Bisphosphonateinduced avascular osteonecrosis of the jaws. Bisphosphonateassociated osteonecrosis is a new disease that is becoming increasingly more common. Patients undergoing treatment with bisphosphonates may develop jaw lesions consisting mainly of bone necrosis. Before we begin to examine the issues as we currently understand them, it is important to discuss what bisphosphonates are, what they are used for, and how they work. Although this has generated a large amount of literature in the last few years, it is difficult to.
Osteonecrosis of the jaw onj occurs specifically in the cells of the maxilla and mandible jaw bones. It has since come under increasing scrutiny especially as it affects not only patients receiving intravenous bisphosphonates for cancer related conditions unrelated to radiotherapy but also those on oral preparations for osteoporosis. Oral bisphosphonate related osteonecrosis of the jaw. Severe osteonecrosis of the jaws in a compromised patient. This series included patients diagnosed with bisphosphonate induced osteonecrosis of the jaws treated by block resection.
It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. Nbisphosphonates cause gastric epithelial injury independent of effects on the. Endodontic implications of bisphosphonateassociated. Normal serum bone markers in bisphosphonateinduced. In study 1, no cases of onj were observ ed in either treatment group. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis bon in order to aid its prompt recognition. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Scintigraphy tc99scan is the most sensitive diagnostic strategy to identify edema and vascular changes. Pdf osteonecrosis of the jaws in patients treated with. Osteonecrosis of the jaw in patients treated with bisphosphonates is a. We compared the extent of bonj on contrastenhanced mr imaging, 18f fluoride petct, and panoramic views derived from standard conebeam ct with clinical pre and intraoperative examinations. In 2002, the food and drug administration fda received first reports related to several patients with cancer, treated with the iv bisphosphonates bp, who developed osteonecrosis of the jaw. Oral bisphosphonates and the risk for osteonecrosis of the. Medicationrelated osteonecrosis of the jaw is an oral complication in cancer patients.
Aug 09, 20 bisphosphonates related osteonecrosis of the jaw bronj is related to the development of avascular osteonecrosis or osteochemonecrosis 1, 2. Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of potential consequences. T1 imaging findings in bisphosphonate related osteonecrosis of jaws. An association between the use of bisphosphonates and osteonecrosis of the maxilla and mandible has recently been described. Yusuf farouk suleman, shabnum meer and russel lurie, bisphosphonateinduced osteonecrosis of the jaws. Bisphosphonateassociated osteonecrosis of the jaws. Although bisphosphonates have been used clinically for more than three decades there have been no documented longterm complications of their effects on the jaws until recently, where there is now growing evidence of the influence of bisphosphonates on osteonecrosis of the jaws. Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well known complication at maxillofacial units around the world.
Normal serum bone markers in bisphosphonateinduced osteonecrosis of the jaws steven lehrer, md,a andre montazem, md, dmd,b lakshmi ramanathan, phd,c melissa pessinminsley, md, phd,d john pfail, dds,e richard g. Bisphosphonateinduced osteonecrosis of the jaws, bone. Osteonecrosis of the jaws in patients treated with. Reconstruction of defects caused by bisphosphonateinduced. Radiographic findings in bisphosphonateassociated osteonecrosis of the jaws. Lowdose bisphosphonates given either orally or intravenously in osteoporosis patients have not been causally linked to the development of osteonecrosis of the jaw. Development of medicationrelated osteonecrosis of the jaw after. The reported incidence of bronj is significantly higher with the iv preparations zoledronic acid and pamidronate while the risk appears to be minimal for. Bisphosphonates and bisphosphonateinduced osteonecrosis of. Bisphosphonate related osteonecrosis of the jaws bronj is a welldescribed clinical condition with consistent radiographic findings. Oral and intravenous bisphosphonate induced osteonecrosis of.
In this article, bisphosphonate associated osteonecrosis or bon will be the terms used to describe an osteonecrosis of the jaws secondary to bisphosphonate therapy. While osteonecrosis can be caused by a number of other factors, this particular form of the condition is called bisphosphonateinduced osteonecrosis of the jaw bionj. Oral and intravenous bisphosphonateinduced osteonecrosis of. Medicationrelated osteonecrosis of the jaw2014 update. The present study describes a model of maxillary osteonecrosis in spraguedawley rats, applying bisphosphonates and examines the changes occurring after tooth extraction. The change is justified to accommodate the growing number of osteonecrosis cases involving the maxilla and mandible associated with other antiresorptive denosumab. Medicationrelated osteonecrosis of the jaw mon, mronj is progressive death of the.
Nature and frequency of bisphosphonate associated osteonecrosis of the jaws in australia. What is bisphosphonateinduced osteonecrosis of the jaw. Axial and coronal computed tomography ct images of the maxillofacial bones figures 2 and 3 demonstrate extensive cortical destruction, osteosclerosis, cortical thickening, and fragmentation of the right maxilla, which extends into the frontal process of the zygomatic bone and pterygoid plates. Oral and intravenous bisphosphonate induced osteonecrosis of the jaws. Osteonecrosis of the jaw international osteoporosis foundation. Reports of this complication have increased recently. The etiology of orn is, however, completely different from the mechanism behind bisphosphonate induced osteonecrosis. Osteonecrosis of the jaw and the role of bisphosphonates. Osteonecrosis of the jaws by intravenous bisphosphonates. Case report a 77yearold male caucasian patient was referred to the stomatology department.
Bisphosphonates and bisphosphonate induced osteonecrosis of the jaws. May 16, 20 advisory task force on bisphosphonaterelated ostenonecrosis of the jaws and american association of oral and maxillofacial surgeons, american association of oral and maxillofacial surgeons position paper on bisphosphonaterelated osteonecrosis of the jaws, journal of oral and maxillofacial surgery, vol. Medicationrelated osteonecrosis of the jaws oxford academic. Bisphosphonate is used to treat osteoporosis, bone metastases, hypercalcemia of malignancies and multiple myeloma. Osteonecrosis of the jaw, commonly called onj, occurs when the jaw bone is exposed and begins to starve from a lack of blood. Patients with multiple myeloma and metastatic carcinoma to the skeleton who are receiving. Medicationrelated osteonecrosis of the jaw wikipedia. However, a causeandeffect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or paget disease of bone. The special committee favors the term medication related osteonecrosis of the jaw mronj. Imaging of bisphosphonateinduced osteonecrosis of the jaw is essential for surgical planning.
Bisphosphonates bps are a widely used class of drugs indicated for the prevention and treatment of postmenopausal and steroidinduced osteoporosis. Mar 29, 2008 osteonecrosis of the jaws associated with bisphosphonate therapy was first identified in 2003 as a condition typified by exposed bone that does not heal after 8 weeks. Bisphosphonate related osteonecrosis of the jaws bronj was initially recognised and reported in the literature in 2002. Bisphosphonateassociated osteonecrosis than the oral bisphosphonates. Since this initial identification, many cases have been reported 811. Bisphosphonate related osteonecrosis of the jaws rev bras reumatol 2011. It has been speculated that the medication, especially longterm i. Bisphosphonate related osteonecrosis of the jaw bronj is defined as exposed necrotic bone in the maxillofacial area that persists for more than 8 weeks in patients with a history of nitrogencontaining bisphosphonate use without a history of radiation exposure. Bisphosphonates and osteonecrosis of the jaws journal of. Bisphosphonates and osteonecrosis of the jaws australian. Bisphosphonaterelated osteonecrosis of the jaw workup. Prevention of osteonecrosis of the jaw onj in patients on. Bisphosphonaterelated osteonecrosis of the jaws bronj is a severe complication that has recently emerged in patients treated with intravenous bisphosphonates for malignant diseases.
Drug related risk factors a bisphosphonate potency. Bisphosphonates are drugs that decrease bone turnover by inhibiting osteoclast activity. Bisphosphonateassociated osteonecrosis of the jaws baonj is a side effect of treatment with bisphosphonate bp. In early 2005 the fda in the united states released a statement saying that osteonecrosis is a risk with all forms of. Bisphosphonate related osteonecrosis of the jaw bronj manifests as exposed, nonvital bone involving the maxillofacial structures. Several etiopathogenic mechanisms of this pathological condi. Endodontic implications of bisphosphonateassociated osteonecrosis of the jaws the guidance in this statement is not intended to substitute for a clinicians independent judgment in light of the conditions and needs of a specific patient. Bisphosphonaterelated osteonecrosis of the jaws rev bras reumatol 2011. Findings in contrastenhanced imaging of the jaws of 11 patients with bisphosphonateinduced osteonecrosis of the jaws findings in contrast. Osteonecrosis of the jaws onj is characterized by the death of bone as a natural consequence of a wide variety of systemic and local factors compromising the blood flow of the bone.
Imaging findings in bisphosphonate induced osteonecrosis of the jaws katarina surlan popovic1, miha kocar2 1 department of neuroradiology, institute of radiology, university medical centre ljubljana, ljubljana, slovenia 2 department of maxillofacial and oral surgery, university medical centre ljubljana, ljubljana, slovenia received 26 may 2010. Hyperbaric oxygen treatment and bisphosphonates induced osteonecrosis of the jaw. Bisphosphonate related osteonecrosis of the jaws bronj is a poorly understood pathologic entity from the standpoints of its nomenclature, frequency, pathogenesis, and best method of treatment. Bisphosphonaterelated osteonecrosis of the jaws bronj is mainly observed in patients with multiple myeloma and bone metastasis from solid tumors receiving iv bisphosphonate therapy. Bisphosphonaterelated osteonecrosis of the jaw scielo. Bisphosphonaterelated osteonecrosis of the jaws bronj is among the most serious ones.
Bisphosphonateinduced osteonecrosis of the jaw request pdf. Concept, diagnosis and classification of bisphosphonateassociated osteonecrosis of the jaws. Even though patients benefit of bp therapy is huge, various side effects may develop. Harper and fung 1, i wish to comment and raise questions on the recent editorial by kahn 2 and article by etminan, et al 3. Pdf bisphosphonateinduced osteonecrosis of the jaws bionj. Introduction bisphosphonate induced osteonecrosis of the jaws onj was first described by marx in the year 2003 1. Request pdf on nov 1, 2009, noam yarom and others published osteonecrosis of the jaws induced by drugs other than bisphosphonates a call to update terminology in light of new data find, read. Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Six cases 4056 patients had previously been identified in all controlled clinical trials and the first postmarketing report was made in december 2002. Harper and fung1, i wish to comment and raise questions on the recent editorial by kahn2 and article by etminan, et al 3. Patients treated with bps may subsequently develop osteonecrosis of the jaw or. Osteonecrosis of the jaw and osteoporosis management. Osteonecrosis of the jaws induced by drugs other than.
Osteonecrosis of the jaw onj is a potentially severe adverse effect of bisphosphonates. In the presence of bp accumulation capable of decreasing bone metabolism, tissue repair following an induced or a physiological trauma does not occur properly. Since 2003, multiple cases of bisphosphonateinduced osteonecrosis of the jaw onj were reported. Clinically it is diagnosed by an area of exposed bone in the mandible, maxilla, or palate that typically heals poorly or does not heal over a period of 6 to 8 weeks. Rarely found in the jaws is a steroidinduced form of osteonecrosis that is much more common in long bones, and, unlike the bisphosphonateinduced necrotic bone, it almost never produces exposed bone. Osteonecrosis of the jaws onj is a complication of antiresorptive medications, such as denosumab or bisphosphonates, prescribed to patients with bone malignancy or osteoporosis. Imaging findings in bisphosphonateinduced osteonecrosis of.
Bisphosphonate related osteonecrosis of the jaws the. Medicationrelated osteonecrosis of the jaw mronj is a rare but severe side. Mar 11, 2019 bisphosphonate related osteonecrosis of the jaw bronj is a condition found in patients who have received intravenous and oral forms of bisphosphonate therapy for various bonerelated conditions. Most cases of osteonecrosis of the jaw happen after a dental extraction. Imaging findings in bisphosphonaterelated osteonecrosis of jaws. Bisphosphonateinduced avascular osteonecrosis of the jaws article in international journal of oral and maxillofacial surgery 357. Page 1 medicationrelated osteonecrosis of the jaw 2014 update. We followed the accepted criteria 20 to establish the diagnosis of onj. Pdf bisphosphonaterelated osteonecrosis of jaw bronj. Article bisphosphonate associated osteonecrosis of the jaw. Bisphosphonateinduced osteonecrosis of the jaw onj. Bisphosphonates have become the standard of care in the treatment of patients with osteoporosis 1,2 and in the prevention and treatment of skeletal.
The aim of this study was to describe the incidence and risk factors of onj in patients with breast cancer or gynecological malignancies receiving bisphosphonates bp. Imaging findings in bisphosphonateinduced osteonecrosis. Since it was first identified in 2003, bisphosphonate induced osteonecrosis has come under growing scrutiny by medical and dental specialists alike because it affects cancer patients receiving intravenous bisphosphonate therapy and osteoporosis patients receiving oral bisphosphonate therapy and yet its presentation of exposed bone is limited to the jaws. Osteonecrosis of the jaws is an increasingly recognised complication of bisphosphonate therapy. History, etiology, prevention, and treatment, second edition robert e. Pathophysiology of bisphosphonatesassociated osteonecrosis of the jaw r01 pa072.
Despite the benefits of these drugs, bisphosphonate related osteonecrosis of the jaw bronj which was first published in the literature in 2003 is a severe side effect of bisphosphonate therapy 47. Imaging findings of bisphosphonate associated osteonecrosis of the jaws. Furthermore, a trend to ward lo wer incidences of infection and tooth loss was observed in the alendronate group. The duration of therapy is important, as longer duration appears to be associated with increased risk of bon development. Bisphosphonate induced osteonecrosis is a chemical toxicity resulting in the death of osteoclasts. Bisphosphonate associated osteonecrosis of the jaw. Bisphosphonateinduced osteonecrosis of the jaw bionj studies have shown that the use of bisphosphonate in patients with cancer is associated with osteonecrosis of the jaw. It can cause persistent pain and infection to the jawbones, and is currently considered incurable. Evidence also suggests bisphosphonates induce apoptosis of osteoclasts.
482 54 132 1076 292 1434 997 1067 49 557 1308 1284 538 247 1191 1632 237 1101 1433 1281 108 1639 621 172 954 1005 879 462 267 1284 1246 1075 1279